Insulet PODD
NASDAQ PODD
$148.16 +1.29 (+0.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Insulet (PODD) Cash from Investing Activities (2010 - 2026)

Insulet's (PODD) quarterly Cash from Investing Activities came in at -$27.7 million in Q1 2026, down 77.56% YoY from -$123.5 million in Q1 2025, and up 81.87% on a QoQ basis from -$152.8 million in Q4 2025.

Insulet (PODD) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Insulet (PODD) has 17 years of Cash from Investing Activities data on file, last reported at -$27.7 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 77.56% year-over-year to -$27.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$234.8 million (down 70.39% YoY) and the FY2025 annual result came in at -$222.7 million, down 52.33% from the prior year.
  • Cash from Investing Activities grew to -$27.7 million in Q1 2026, from -$152.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$15.6 million in Q1 2025 to a low of -$152.8 million in Q4 2025.
  • A 5-year average of -$41.6 million and a median of -$29.3 million in 2024 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 177.87% — and 2023, when it soared 64.25%.
  • Tracing PODD's Cash from Investing Activities over 5 years: stood at -$88.4 million in 2022, then soared by 64.25% to -$31.6 million in 2023, then sank by 115.19% to -$68.0 million in 2024, then slumped by 124.71% to -$152.8 million in 2025, then soared by 81.87% to -$27.7 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$27.7 million (Q1 2026), -$152.8 million (Q4 2025), and -$31.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 Insulet 10.27 Bn 9.74 Bn 562.60 Mn -37.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.40 Mn
Jun 30, 2026 -37.40 Mn
Mar 31, 2026 -27.70 Mn
Mar 31, 2026 -27.70 Mn
Dec 31, 2025 -152.80 Mn
Dec 31, 2025 -152.80 Mn
Sep 30, 2025 -31.00 Mn
Sep 30, 2025 -31.00 Mn
Jun 30, 2025 -23.30 Mn
Jun 30, 2025 -23.30 Mn
Mar 31, 2025 -15.60 Mn
Mar 31, 2025 -15.60 Mn
Dec 31, 2024 -68.00 Mn
Dec 31, 2024 -68.00 Mn
Sep 30, 2024 -29.30 Mn
Sep 30, 2024 -29.30 Mn
Jun 30, 2024 -24.90 Mn
Jun 30, 2024 -24.90 Mn
Mar 31, 2024 -24.00 Mn
Mar 31, 2024 -24.00 Mn